GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 915 filers reported holding GLAXOSMITHKLINE PLC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $207,000 | -21.3% | 4,753 | -15.1% | 0.01% | +50.0% |
| Q4 2019 | $263,000 | -71.8% | 5,599 | -74.3% | 0.00% | -78.9% |
| Q3 2019 | $931,000 | +34.5% | 21,825 | +31.7% | 0.02% | +11.8% |
| Q1 2019 | $692,000 | +26.0% | 16,570 | +27.4% | 0.02% | +142.9% |
| Q1 2017 | $549,000 | +44.1% | 13,002 | +31.3% | 0.01% | +75.0% |
| Q4 2016 | $381,000 | -11.4% | 9,900 | -0.2% | 0.00% | -20.0% |
| Q2 2016 | $430,000 | – | 9,922 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |